Lifecome Biochemistry Co Ltd (002868) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Lifecome Biochemistry Co Ltd (002868) has a cash flow conversion efficiency ratio of -0.127x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥13.24 Million ≈ $1.94 Million USD) by net assets (CN¥-104.52 Million ≈ $-15.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Lifecome Biochemistry Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Lifecome Biochemistry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 002868 total liabilities for a breakdown of total debt and financial obligations.
Lifecome Biochemistry Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lifecome Biochemistry Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Iress Ltd
AU:IRE
|
0.070x |
|
Evertz Technologies Limited
TO:ET
|
-0.021x |
|
Yueyang Xingchang Petro-Chemical Co Ltd
SHE:000819
|
0.009x |
|
CNB Financial Corporation
NASDAQ:CCNE
|
0.008x |
|
Bangkok Airways Public Company Limited
BK:BA
|
0.076x |
|
Evommune, Inc.
NYSE:EVMN
|
-0.081x |
|
Lotus Technology Inc.
NASDAQ:LOT
|
0.672x |
|
Minerals 260 Ltd
AU:MI6
|
-0.038x |
Annual Cash Flow Conversion Efficiency for Lifecome Biochemistry Co Ltd (2012–2024)
The table below shows the annual cash flow conversion efficiency of Lifecome Biochemistry Co Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see 002868 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥-24.54 Million ≈ $-3.59 Million |
CN¥141.41 Million ≈ $20.69 Million |
-5.763x | -1177.91% |
| 2023-12-31 | CN¥414.11 Million ≈ $60.60 Million |
CN¥-186.76 Million ≈ $-27.33 Million |
-0.451x | -2959.86% |
| 2022-12-31 | CN¥599.30 Million ≈ $87.70 Million |
CN¥-8.83 Million ≈ $-1.29 Million |
-0.015x | -130.26% |
| 2021-12-31 | CN¥722.02 Million ≈ $105.65 Million |
CN¥35.17 Million ≈ $5.15 Million |
0.049x | -58.66% |
| 2020-12-31 | CN¥769.94 Million ≈ $112.67 Million |
CN¥90.72 Million ≈ $13.28 Million |
0.118x | +23.81% |
| 2019-12-31 | CN¥778.50 Million ≈ $113.92 Million |
CN¥74.09 Million ≈ $10.84 Million |
0.095x | -15.82% |
| 2018-12-31 | CN¥740.37 Million ≈ $108.34 Million |
CN¥83.70 Million ≈ $12.25 Million |
0.113x | -18.17% |
| 2017-12-31 | CN¥695.68 Million ≈ $101.80 Million |
CN¥96.11 Million ≈ $14.06 Million |
0.138x | -72.32% |
| 2016-12-31 | CN¥271.34 Million ≈ $39.71 Million |
CN¥135.41 Million ≈ $19.81 Million |
0.499x | -6.18% |
| 2015-12-31 | CN¥238.98 Million ≈ $34.97 Million |
CN¥127.11 Million ≈ $18.60 Million |
0.532x | +61.76% |
| 2014-12-31 | CN¥190.87 Million ≈ $27.93 Million |
CN¥62.76 Million ≈ $9.18 Million |
0.329x | -28.29% |
| 2013-12-31 | CN¥169.42 Million ≈ $24.79 Million |
CN¥77.68 Million ≈ $11.37 Million |
0.458x | +17.76% |
| 2012-12-31 | CN¥156.45 Million ≈ $22.89 Million |
CN¥60.92 Million ≈ $8.91 Million |
0.389x | -- |
About Lifecome Biochemistry Co Ltd
Lifecome Biochemistry Co.,Ltd. operates as a biopharmaceutical company in China. It offers bacitracin zinc products, colistin sulfate products, probiotics products, bacitracin methylene disalicylate products, biological preservatives, photovoltaic film products, etc.; veterinary drugs; and food preservatives. The company was founded in 2003 and is based in Pucheng, China.